Start › Rak prostaty › Minnesota › Minneapolis
Badania kliniczne dla Rak prostaty w mieście Minneapolis, MN
23 badań dla Rak prostaty szuka uczestników w ośrodkach w mieście Minneapolis i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi dalej
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 mi dalej
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekrutacjaFaza 2
- Hennepin County Medical Center, Minneapolis
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
RekrutacjaFaza 1
- University Of Minnesota, Minneapolis
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
RekrutacjaFaza 1
- M Health Fairview Clinics and Surgery Center, Minneapolis
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekrutacjaFaza 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park · 5 mi dalej
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
RekrutacjaFaza 3
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
RekrutacjaFaza 2
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RekrutacjaFaza 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park · 5 mi dalej
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekrutacjaFaza 3
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi dalej
The Vanguard Study: Testing a New Way to Screen for Cancer
RekrutacjaZapraszamy zdrowych ochotników
- Minneapolis VA Medical Center, Minneapolis
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
RekrutacjaFaza 1/2
- Research Site, Minneapolis
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
RekrutacjaFaza 2
- Masonic Cancer Center, Minneapolis
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RekrutacjaFaza 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- i 1 więcej
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RekrutacjaFaza 1
- University of Minnesota Medical Center, Minneapolis
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RekrutacjaFaza 1
- Minnesota Oncology Hematology, Minneapolis
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
RekrutacjaFaza 1
- University of Minnesota, Minneapolis
Axelopran for Advanced Cancer in Patients Receiving Opioids
RekrutacjaFaza 2
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park · 5 mi dalej
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RekrutacjaFaza 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- i 1 więcej
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Allina Health Cancer Institute, Minneapolis
Vitamin D for Prostate Endocrine Therapy
RekrutacjaFaza 3
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi dalej
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekrutacjaFaza 3
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi dalej
Badania dla Rak prostaty w innych miastach
- New York City, NY103 badań
- Houston, TX76 badań
- Los Angeles, CA61 badań
- Boston, MA59 badań
- St. Louis, MO46 badań
- Chicago, IL45 badań
- San Francisco, CA45 badań
- Philadelphia, PA44 badań
- Baltimore, MD43 badań
- Nashville, TN42 badań
- Seattle, WA42 badań
- Washington, DC38 badań
Inne badania w mieście Minneapolis
- Rak piersi27 badań
- Niedrobnokomórkowy rak płuca26 badań
- Rak jajnika24 badań
- Nowotwory (wszystkie typy)22 badań
- Niewydolność serca21 badań
- Rak płuc20 badań
- Ostra białaczka szpikowa20 badań
- Rak jelita grubego i odbytnicy19 badań
- Rak endometrium18 badań
- Choroba Parkinsona17 badań
- Choroby układu sercowo-naczyniowego15 badań
- Choroba wieńcowa13 badań
Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.